BOSTON SCIENTIFIC CORPORATION Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain
BOSTON SCIENTIFIC CORPORATION (BSX) reported Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain of $184.00 million for the 12-month period ending 2018-12-31, per its 10-K filed 2021-02-23.
Discontinued › Income Statement › Other Income
us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain · last filed 2021-02-23
- BOSTON SCIENTIFIC CORPORATION business combination, step acquisition, equity interest in acquiree, remeasurement gain for the quarter ending 2018-12-31 was $2.00M.
- BOSTON SCIENTIFIC CORPORATION business combination, step acquisition, equity interest in acquiree, remeasurement gain for the quarter ending 2018-09-30 was $142.00M.
- BOSTON SCIENTIFIC CORPORATION business combination, step acquisition, equity interest in acquiree, remeasurement gain for the quarter ending 2014-09-30 was $19.00M.
- BOSTON SCIENTIFIC CORPORATION business combination, step acquisition, equity interest in acquiree, remeasurement gain for the quarter ending 2011-03-31 was $38.00M.
- BOSTON SCIENTIFIC CORPORATION business combination, step acquisition, equity interest in acquiree, remeasurement gain for fiscal 2018 was $184.00M.
| Period end | Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain 3 month | Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain 6 month | Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain 9 month | Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain 12 month |
|---|---|---|---|---|
| 2018-12-31 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $144.00M derived: sum of 2 quarters · filed 2021-02-23 | $184.00M 10-K · filed 2021-02-23 | |
| 2018-09-30 | $142.00M 10-Q · filed 2019-11-05 | $182.00M 10-Q · filed 2019-11-05 | ||
| 2014-09-30 | $19.00M 10-Q · filed 2015-11-04 | |||
| 2011-03-31 | $38.00M 10-Q · filed 2012-05-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |